Evolent Health (EVH) Operating Expenses (2015 - 2026)

Evolent Health's Operating Expenses history runs 12 years deep, the most recent figure standing at $506.8 million for Q1 2026.

• In Q1 2026, Operating Expenses rose 4.45% year-over-year to $506.8 million; the TTM figure through Mar 2026 stood at $2.3 billion (down 4.92% YoY), while the FY2025 annual figure was $2.3 billion, down 11.9% from the prior year.
• Operating Expenses was $506.8 million for Q1 2026 at Evolent Health, down from $877.0 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $877.0 million in Q4 2025 to a low of $299.9 million in Q1 2022.
• Historically, Operating Expenses has averaged $516.0 million across 5 years, with a median of $490.7 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Operating Expenses surged 55.74% in 2023, then slumped 30.32% in 2025.
• A 5-year view of Operating Expenses shows it stood at $384.3 million in 2022, then soared by 50.24% to $577.4 million in 2023, then gained by 15.19% to $665.1 million in 2024, then soared by 31.84% to $877.0 million in 2025, then tumbled by 42.2% to $506.8 million in 2026.
• The last three Operating Expenses figures came in at $506.8 million (Q1 2026), $877.0 million (Q4 2025), and $478.6 million (Q3 2025), per Business Quant data.